Ellington Management Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-3,000	Closed	-$299K	–	235
2020 Q1	$299K	Buy	3,000 +900	+43%	+$116K	0.09%	328
2019 Q4	$313K	Buy	+2,100	New	+$286K	0.09%	296
2019 Q2	–	Sell	-4,200	Closed	-$600K	–	683
2019 Q1	$600K	Buy	+4,200	New	+$548K	0.13%	203
2018 Q1	–	Sell	-4,700	Closed	-$633K	–	929
2017 Q4	$633K	Buy	+4,700	New	+$652K	0.18%	163
2016 Q4	–	Sell	-3,600	Closed	-$437K	–	675
2016 Q3	$437K	Buy	+3,600	New	+$485K	0.12%	321
2016 Q1	–	Sell	-1,500	Closed	-$211K	–	598
2015 Q4	$211K	Sell	1,500 -951	-39%	-$132K	0.1%	439
2015 Q3	$326K	Buy	+2,451	New	+$422K	0.09%	378
2015 Q1	–	Sell	-1,700	Closed	-$278K	–	749
2014 Q4	$278K	Buy	+1,700	New	+$282K	0.09%	355
2014 Q2	–	Sell	-2,400	Closed	-$333K	–	564
2014 Q1	$333K	Buy	+2,400	New	+$361K	0.1%	325